Evidence map›Paper›PMID 38230877›Full record

ArticleThe Journal of infectious diseases2024

Torque Teno Virus Load Is Associated With Centers for Disease Control and Prevention Stage and CD4+ Cell Count in People Living With Human Immunodeficiency Virus but Seems Unrelated to AIDS-Defining Events and Human Pegivirus Load.

Pia L Esser, Gibran H Rubio Quintanares, Bettina Langhans, Eva Heger, Michael Böhm, Björn-Erik O L E Jensen, Stefan Esser, Nadine Lübke, Gerd Fätkenheuer, Thomas Lengauer and 7 more

Erratum issuedAbstract readMulticenter Study
In one paragraph

Article in The Journal of infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Pia L EsserDepartment of Internal Medicine I, University Hospital Bonn, Bonn, Germany.
Gibran H Rubio QuintanaresInstitute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Bettina LanghansDepartment of Internal Medicine I, University Hospital Bonn, Bonn, Germany.
Eva HegerInstitute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Michael BöhmInstitute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Björn-Erik O L E JensenDepartment of Gastroenterology, Hepatology and Infectious Diseases, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Stefan EsserDepartment of Dermatology, University Hospital Essen, Essen, Germany.
Nadine LübkeInstitute of Virology, University Hospital Düsseldorf, Düsseldorf, Germany.ORCID 0000-0003-3820-7915
Gerd FätkenheuerDepartment of Internal Medicine I, University Hospital Cologne, Cologne, Germany.
Thomas LengauerInstitute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Florian KleinInstitute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Mark OetteClinic for General Medicine, Gastroenterology, and Infectious Diseases, Augustinerinnen Hospital, Cologne, Germany.
Juergen K RockstrohDepartment of Internal Medicine I, University Hospital Bonn, Bonn, Germany.
Christoph BoeseckeDepartment of Internal Medicine I, University Hospital Bonn, Bonn, Germany.
Veronica Di CristanzianoInstitute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Rolf KaiserInstitute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Martin PirklInstitute of Virology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.ORCID 0000-0002-6986-0813

Funding

DZIF TTUHIV Immunecontrol and EuResist
6 · The paper itself

Abstract

backgroundTorque teno virus (TTV) is part of the human virome. TTV load was related to the immune status in patients after organ transplantation. We hypothesize that TTV load could be an additional marker for immune function in people living with HIV (PLWH).

methodsIn this analysis, serum samples of PLWH from the RESINA multicenter cohort were reanalyzed for TTV. Investigated clinical and epidemiological parameters included human pegivirus load, patient age and sex, HIV load, CD4+ T-cell count (Centers for Disease Control and Prevention [CDC] stage 1, 2, or 3), and CDC clinical stage (1993 CDC classification system; stage A, B, or C) before initiation of antiretroviral therapy. Regression analysis was used to detect possible associations among parameters.

resultsOur analysis confirmed TTV as a strong predictor of CD4+ T-cell count and CDC class 3. This relationship was used to propose a first classification of TTV load with regard to clinical stage. We found no association with clinical CDC stages A-C. The human pegivirus load was inversely correlated with HIV load but not TTV load.

conclusionsTTV load was associated with immunodeficiency in PLWH. Neither TTV nor HIV load were predictive for the clinical categories of HIV infection.

Indexed as

DNA Virus InfectionsHIV InfectionsTorque teno virusViral LoadAcquired Immunodeficiency SyndromeAdultCD4 Lymphocyte CountCenters for Disease Control and Prevention, U.S.Cohort StudiesFemaleFlaviviridaeHumansMaleMiddle AgedUnited StatesbiomarkerHIVHPgVimmunodeficiencyTTV

Identifiers

PMID38230877
PMCPMC11326818

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.